--- title: "生物素成分市场展望 2026-2036：根据 FMI 报告，全球市场预计到 2036 年将达到 106.1 亿美元，年复合增长率为 10.90%" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/279546640.md" description: "全球生物素成分市场预计将从 2025 年的 34 亿美元增长到 2036 年的 106.1 亿美元，年均增长率为 10.90%。这一增长受到制药、补充剂和美容产品需求上升的推动，受健康趋势的影响。固体生物素预计将主导市场，而制药部门将占据最大份额。亚太地区，特别是中国和印度，正成为一个高增长区域。主要参与者包括 DSM、Lonza 和 BASF，专注于高纯度配方和合规性" datetime: "2026-03-18T06:56:08.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/279546640.md) - [en](https://longbridge.com/en/news/279546640.md) - [zh-HK](https://longbridge.com/zh-HK/news/279546640.md) --- # 生物素成分市场展望 2026-2036：根据 FMI 报告，全球市场预计到 2036 年将达到 106.1 亿美元，年复合增长率为 10.90% _**Global biotin ingredients market grows with rising demand from pharmaceuticals, supplements, and beauty products, driven by wellness trends and advanced formulations**_ **NEWARK, DE / ACCESS Newswire / March 18, 2026 /** According to analysis by **Future Market Insights (FMI)**, the global **biotin ingredients market** is entering a phase of accelerated expansion as demand converges across nutraceutical, pharmaceutical, and beauty-from-within product segments. Rising consumer awareness around hair, skin, and nail health, combined with increasing pharmaceutical applications, is reshaping procurement and formulation strategies across industries. The market was valued at USD 3.40 billion in 2025 and is projected to reach **USD 3.77 billion in 2026**. Over the forecast period, demand is expected to grow at a robust **CAGR of 10.90%,** ultimately reaching **USD 10.61 billion by 2036**. This strong growth trajectory reflects a structural shift toward preventive healthcare and functional nutrition. Rather than serving as a niche vitamin ingredient, biotin is increasingly being positioned as a core functional component across supplements, cosmetics, fortified foods, and pharmaceutical formulations. **Get Access of Report Sample:** https://www.futuremarketinsights.com/reports/sample/rep-gb-25713 **Biotin Ingredients Market Snapshot** - Market Value (2025): USD 3.40 Billion - Forecast Value (2036): USD 10.61 Billion - Forecast CAGR (2026-2036): 10.90% - Leading Type: Solid Biotin (71.3%) - Top Application Segment: Pharmaceutical (34.0%) - Leading Distribution Channel: Direct Sales (46.5%) - Fastest Growing Market: China **Beauty-from-Within Trends Driving Ingredient Demand** A primary force driving the biotin ingredients market is the rapid rise of beauty-from-within trends, where consumers increasingly rely on ingestible supplements for visible improvements in hair, skin, and nail health. Manufacturers are responding by developing high-dose, bioavailable formulations that deliver measurable outcomes. At the same time, pharmaceutical demand remains strong due to biotin's established role in treating biotinidase deficiency and metabolic disorders. FMI analysts note that this dual demand-clinical and cosmetic-is elevating biotin from a commodity vitamin to a high-value functional ingredient. **Supply Chain Concentration and Quality Specifications Shape Procurement** Procurement strategies are increasingly influenced by supply chain concentration and stringent quality requirements. A significant portion of global biotin production is concentrated among fermentation-based manufacturers in China, creating sourcing risks for pharmaceutical-grade material. Key procurement challenges include: - Ensuring pharmacopoeia-grade purity and regulatory compliance - Managing price volatility linked to fermentation feedstock costs - Mitigating single-source supply risks As a result, pharmaceutical and cosmetic manufacturers are increasingly adopting dual-sourcing strategies and long-term supplier agreements to ensure consistency and security. **Solid Biotin Leads Product Segment** By type, solid biotin is projected to dominate the market with a 71.3% share in 2026. Its leadership is driven by operational advantages such as: - Superior stability during storage and processing - Ease of handling in tableting and capsule filling - Precise dosing capabilities for pharmaceutical and nutraceutical applications These benefits make solid biotin the preferred format across large-scale manufacturing environments. **Pharmaceutical Segment Drives Application Demand** The pharmaceutical segment is expected to hold the largest share, accounting for 34.0% of total demand in 2026. This dominance is supported by: - Established therapeutic use in biotin deficiency treatment - Growing off-label use in high-dose wellness formulations - Increasing demand for clinically validated ingredients Pharmaceutical-grade biotin continues to command premium pricing due to strict quality specifications and regulatory requirements. **Direct Sales Channel Dominates Distribution** By distribution channel, direct sales are projected to account for 46.5% of the market in 2026. This reflects the B2B nature of the industry, where manufacturers procure ingredients directly from API suppliers under long-term quality agreements. Meanwhile, online channels are emerging as the fastest-growing segment, enabling smaller supplement brands to source ingredients more efficiently and bypass traditional intermediaries. **Asia-Pacific Emerges as a High-Growth Region** Regionally, the biotin ingredients market is witnessing strong growth across Asia-Pacific, driven by expanding manufacturing capacity and rising consumer demand for wellness products. **Biotin Ingredients Market Growth by Country (2026-2036)** - China: 14.7% - India: 13.6% - Germany: 12.5% - France: 11.4% - United Kingdom: 10.4% - United States: 9.3% - Brazil: 8.2% China leads global growth, supported by large-scale fermentation production and increasing domestic consumption. India follows closely, driven by rising awareness of nutritional supplements and expanding middle-class demand. **Innovation in Bioavailability and Formulation Unlocking Opportunities** Technological advancements are enhancing the performance and application scope of biotin ingredients. Manufacturers are investing in advanced encapsulation techniques and delivery systems to improve bioavailability and stability. At the same time, integration into functional foods and beverages is opening new revenue streams, with applications expanding into protein drinks, cereals, and fortified snacks. These innovations are positioning biotin as a versatile ingredient across multiple end-use industries. **Key Players in the Biotin Ingredients Market** Leading companies operating in the global market include: - DSM - Lonza - BASF - Merck - Evonik - Archer Daniels Midland (ADM) - Cargill - Ingredion - Glanbia Nutritionals - Kerry Group - Brenntag - IMCD - Prinova Group - Balchem - Associated British Foods (ABF) These players are focusing on high-purity formulations, regulatory compliance, and global supply chain capabilities to strengthen their competitive positioning. **Market Outlook: Biotin Becomes Core to Wellness Formulations** The long-term outlook for the biotin ingredients market remains highly positive as demand for preventive healthcare, functional nutrition, and beauty supplements continues to rise. With increasing integration across pharmaceuticals, nutraceuticals, cosmetics, and functional foods, biotin is transitioning from a supplementary ingredient to a foundational component in modern wellness product development. As innovation in formulation, sourcing strategies, and delivery mechanisms accelerates, the market is set for sustained high-growth through 2036-cementing biotin's role as a key driver in next-generation health and beauty solutions. **For an in-depth analysis of evolving formulation trends and to access the complete strategic outlook for the Biotin Ingredients Market through 2036, Full Report Request -** https://www.futuremarketinsights.com/reports/biotin-ingredients-market **Related Reports:** Biotin Supplement Market: https://www.futuremarketinsights.com/reports/biotin-supplements-market Biotin Gummies Market: https://www.futuremarketinsights.com/reports/biotin-gummies-market Milk Ingredients Market: https://www.futuremarketinsights.com/reports/milk-ingredients-market Malt Ingredients Market: https://www.futuremarketinsights.com/reports/malt-ingredients-market Bean Ingredients Market: https://www.futuremarketinsights.com/reports/bean-ingredients-market **About Future Market Insights (FMI)** Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. Headquartered in Delaware, USA, with a global delivery center in India and offices in the UK and UAE, FMI delivers actionable insights to businesses across industries including automotive, technology, consumer products, manufacturing, energy, and chemicals. An ESOMAR-certified research organization, FMI provides custom and syndicated market reports and consulting services, supporting both Fortune 1,000 companies and SMEs. Its team of 300+ experienced analysts ensures credible, data-driven insights to help clients navigate global markets and identify growth opportunities. **For Press & Corporate Inquiries** Rahul Singh AVP - Marketing and Growth Strategy Future Market Insights, Inc. +91 8600020075 For Sales - sales@futuremarketinsights.com For Media - Rahul.singh@futuremarketinsights.com For web - https://www.futuremarketinsights.com/ **SOURCE:** Future Market Insights, Inc. View the original press release on ACCESS Newswire ### 相关股票 - [PBE.US](https://longbridge.com/zh-CN/quote/PBE.US.md) - [SY1.DE](https://longbridge.com/zh-CN/quote/SY1.DE.md) - [SBIO.US](https://longbridge.com/zh-CN/quote/SBIO.US.md) - [XBI.US](https://longbridge.com/zh-CN/quote/XBI.US.md) - [O6Z.SG](https://longbridge.com/zh-CN/quote/O6Z.SG.md) - [SHF.DE](https://longbridge.com/zh-CN/quote/SHF.DE.md) - [LABU.US](https://longbridge.com/zh-CN/quote/LABU.US.md) - [BAS.DE](https://longbridge.com/zh-CN/quote/BAS.DE.md) - [BASFY.US](https://longbridge.com/zh-CN/quote/BASFY.US.md) - [BIB.US](https://longbridge.com/zh-CN/quote/BIB.US.md) - [BBH.US](https://longbridge.com/zh-CN/quote/BBH.US.md) - [FBT.US](https://longbridge.com/zh-CN/quote/FBT.US.md) - [SAC.DE](https://longbridge.com/zh-CN/quote/SAC.DE.md) - [IBB.US](https://longbridge.com/zh-CN/quote/IBB.US.md) - [LZAGY.US](https://longbridge.com/zh-CN/quote/LZAGY.US.md) ## 相关资讯与研究 - [巴斯夫将进一步削减成本，重点关注核心业务](https://longbridge.com/zh-CN/news/287098958.md) - [美国启动对越南化学品进口的调查](https://longbridge.com/zh-CN/news/287007343.md) - [制药巨头集体拥抱 AI 智能体：百时美施贵宝向 3 万员工推广 Claude](https://longbridge.com/zh-CN/news/287074661.md) - [CAR-T 迎接新时代](https://longbridge.com/zh-CN/news/286999381.md) - [创胜集团医药-B 合作伙伴 INHIBRX 报告 OZEKIBART 的 CRC 最新积极数据并宣布就治疗软骨肉瘤提交美国 BLA 申请](https://longbridge.com/zh-CN/news/287126678.md)